Stay updated on Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page.

Latest updates to the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page
- Check4 days agoChange DetectedAdded a government funding status notice and updated the page revision label from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0; Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, a minor update with no visible impact on the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedExpanded the Locations section with a global list of trial sites (US, Argentina, Austria, etc.) and removed several previously listed sites. This update changes where participants can enroll in the study.SummaryDifference2%

- Check75 days agoChange DetectedAdded a note that PubMed publications are automatically filled and may not be about the study, and updated the page revision to v3.3.2 (previously v3.2.0).SummaryDifference0.0%

- Check82 days agoChange DetectedAdded Tainan, Taiwan, 71004 as a study location and removed Tainan City, Taiwan, 71004 to standardize the listing.SummaryDifference0.1%

Stay in the know with updates to Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page.